Clinical trial
Negative Pressure Applied by the Equinox Mercury™ Multi-Pressure Dial to Lower and Modulate Intraocular Pressure in Subjects With Severe Open Angle Glaucoma (The Ranger Study)
NCT04632329 is registered in ClinicalTrials.gov with Equinox as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Negative Pressure Applied by the Equinox Mercury™ Multi-Pressure Dial to Lower and Modulate Intraocular Pressure in Subjects With Severe Open Angle Glaucoma (The Ranger Study)
- Lead sponsor
- Equinox
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 28, 2020
- Completion date
- August 19, 2021
- Enrollment
- 64 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.